As evidence of the growing significance of cell or gene therapy, experts predict up to thirteen new marketing approvals in the USA and EU for 2023 alone.

For clinical research in this sector, there are often special requirements for ethical oversight, biosafety, facilities, equipment, and training.

Panelists will provide some introductory context for those that may be new to cell and gene therapy, as well as tips, tricks, and best practices for safe and efficient study planning.